Stocks
Novo Nordisk A/SNVO
NYSEHealthcarePharmaceuticals$37.96-0.16%
A Denmark-based pharmaceutical manufacturer focused on treatments for diabetes, obesity, and other chronic metabolic diseases. Its portfolio includes insulin products and GLP-1 therapies such as Ozempic and Wegovy, which have driven rapid revenue growth and reshaped the global obesity treatment mark...
Market Cap: $168.7B52W Range: $35.85 – $82.57
Congressional Interest in Novo Nordisk A/S (NVO)
11 members of Congress have disclosed 32 trades in Novo Nordisk A/S (NVO), a Healthcare company. The buy/sell breakdown shows 14 purchases versus 18 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
32
Unique Politicians
11
Buys
14
Sells
18
Who in Congress Is Trading NVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-12 | Daniel Goldman | sell | $100K – $250K |
| 2023-07-10 | Daniel Goldman | sell | $250K – $500K |